Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


USP standards for infant formula

This article was originally published in The Tan Sheet

Executive Summary

The U.S. Pharmacopeia proposes adding to the Food Chemicals Codex three nucleotides found in breast milk and commonly added to infant formula, and two DHA oils. USP will add the new voluntary industry standards to the codex following a three-month public comment period ending March 31 to enhance the quality and safety of infant formulas and functional foods. The proposed nucleotide standards - for disodium 5'-uridylate, 5'-adenylic acid and 5'-cytidylic acid - designate the identity, purity and impurities of the ingredients and validated test methods, USP says. The proposed DHA standards are for DHA algal oil, crypthecodinium type and DHA algal oil, schizochytrium type. During a Jan. 14 interview, USP Director of Food Standards Markus Lipp said the standards allow marketers to approach suppliers with a set of minimum requirements for products, and allow suppliers to promote their adherence to the standards to set themselves apart from competitors

You may also be interested in...

QUOTED. 28 January 2020. Steven Falowski.

Abbott is encouraged by results from two studies of its Proclaim XR neurostimulation system for chronic pain, presented at the annual North American Neuromodulation Society (NANS) meeting in Las Vegas. See what Steven Falowski of Neurosurgical Associates of Lancester in Pennsylvania said about it here.

Japan Phase III Failure To End Mono Opdivo Hopes In Ovarian Cancer?

While disappointing result will probably put an end to single-drug plans in ovarian cancer, the blockbuster anti-PD-1 immunotherapy remains in combination development for the indication.

Unilever Hit With Class Action Over Mercury-Laced Pond’s Cream Originating In Mexico

According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts